Thursday, December 17, 2020

#AIEye #Podcast #498: GBT (OTCPINK: $GTCH) Developing Expert System for qTerm Device, Predictiv AI (TSXV: $PAI.V) Donates ThermalPass Fever Detection System; #Artificialintelligence

#AIEye #Podcast #498: GBT (OTCPINK: $GTCH) Developing Expert System for qTerm Device, Predictiv AI (TSXV: $PAI.V) Donates ThermalPass Fever Detection System; #Artificialintelligence

 

Global #AI in Drug Development and Discovery to Reach $4.815 Billion by 2027

 


Point Roberts WA, Vancouver BC – December 17, 2020  – Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of  The AI Eye-  watching stock news, deal tracker and advancements in artificial intelligence  –  featuring technology company GBT Technologies Inc. (OTCPINK:GTCH).

 

Listen to today’s podcast:

https://www.investorideas.com/Audio/Podcasts/2020/121720-AI-Eye.mp3

 

Read this in full at https://www.investorideas.com/news/2020/artificial-intelligence/12171GBT-Predictiv.asp

 

Hear the Ai Eye on Spotify  

 

Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence

 

Stocks discussed: (OTCPINK:GTCH) (TSXV:PAI)

 

GBT Tokenize Corp., the joint venture of GBT Technologies Inc. (OTC PINK:GTCH), is developing an expert system – an artificial intelligence based computer program that solves problems that would usually require a human expert – based flow for its qTerm device mobile application. The aim of this, according to the press release, “will be to integrate machine learning functions to allow the expert system to acquire more and more knowledge from past experience and various external sources.” Danny Rittman, GBT's CTO, explained:

 

"We are preparing qTerm infrastructure for our qTerm vitals device and our goal is to develop an advanced flow for its mobile application. The mobile application flow is targeted to work with a backend server and together to run an expert system that will use a knowledge database and an inference engine. We believe that our qTerm device will become a health monitor device for users, enabling health-aware life. We believe this type of system can save lives for users with existing conditions.”

 

Predictiv AI Inc. (TSXV:PAI) has donated one of its ThermalPass fever detection systems to the Flemingdon Food Bank in Ontario, Canada, to “help keep patrons, staff, and volunteers, healthy and safe as demand for food banks continues to increase amid this busy and challenging holiday season.” Michael Lende, President and CEO of Predictiv AI, commented:

 

"ThermalPass can play an important role in the health and peace of mind of patrons, volunteers, and staff as it identifies individuals with an elevated temperature accurately and efficiently. Predictiv AI is proud to do our part in helping support the community during these difficult times."

 

Global AI in Drug Development and Discovery to Reach $4.815 Billion by 2027

 

A report published by Allied Market Research finds that the global AI in Drug Development and Discovery market will grow from $520 million in 2019 to $4.815 billion by 2027 with a compound annual growth rate (CAGR) of 31.6 percent in the forecast period 2020-2027. An excerpt from the report overview outlines the role of AI in the market:

 

Artificial intelligence has significant applications in the drug discovery field as it helps track diseases, create disease cures and predict which animal viruses appear to mutate. Artificial intelligence has been known to enhance R&D in drug discovery, which has helped researchers to discover chronic disease treatments. Drug discovery and development in the fields of medicine, pharmacology, and biotechnology are processes for the creation, design, and procurement of a drug through identifying a biological target, such as enzyme protein, gene, or receptor. Previously, the drugs were discovered by identifying the active ingredient conventional treatments. Thus, drug discovery is the first step in the process of identifying potential novel drugs and their medicinal purpose. New criteria for drugs are measured based on their bioavailability, efficacy, potency, and toxicity.

 

Sam Mowers, Investorideas.com

 

Read and hear other editions of the AI  Eye

 

For a list of artificial intelligence stocks on Investorideas.com visit here

Investors can trade these stocks and other ideas on our site using our  list of top stock trading apps including Robinhood , Acorn, Stash  and others.

About GBT Technologies Inc.

GBT Technologies Inc. (OTC PINK: GTCH) (“GBT”) (http://gbtti.com) is a development-stage company which considers itself a native IoT creator, developing Internet of Things (IoT) and Artificial Intelligence (AI) enabled mobile technology platforms.  GBT has a portfolio of Intellectual Property that, when commercialized, will include smart microchips, mobile and security applications and protocols, and supporting cloud software.  GBT’s system envisions the creation of a global mesh network.  The core of the system will be its advanced microchip technology that can be installed in any mobile or fixed device worldwide. GBT envisions this system as a low-cost, secure, private mesh network between any enabled devices, providing shared processing, advanced mobile database management/sharing and enhanced mobile features as an alternative to traditional carrier services.

 

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

The Investorideas.com podcasts are also available on iTunes,  Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.

 

Visit the Podcast page at Investorideas.com:

https://www.investorideas.com/Audio/

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com

Disclosure GTCH is a paid featured ai stock on investorideas

newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com  Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

The AI Eye-  Watching stock news, deal tracker and  advancements in artificial intelligence is an original content brand of Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 




Get more Technology stock investor ideas - news, articles, podcasts and stock directories

No comments: